Mankind Pharma [MANKIND] vs Torrent [TORNTPHARM] Detailed Stock Comparison

Mankind Pharma

NSE
Loading...

Torrent

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Mankind Pharma wins in 5 metrics, Torrent wins in 15 metrics, with 0 ties. Torrent appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricMankind PharmaTorrentBetter
P/E Ratio (TTM)54.9560.60Mankind Pharma
Price-to-Book Ratio7.3415.96Mankind Pharma
Debt-to-Equity Ratio58.4342.81Torrent
PEG Ratio-2.663.05Mankind Pharma
EV/EBITDA35.9132.56Torrent
Profit Margin (TTM)14.66%16.92%Torrent
Operating Margin (TTM)17.59%26.15%Torrent
EBITDA Margin (TTM)17.59%26.15%Torrent
Return on Equity13.67%25.18%Torrent
Return on Assets (TTM)7.17%12.75%Torrent
Free Cash Flow (TTM)$18.83B$19.73BTorrent
Dividend Yield0.04%17.47%Torrent
1-Year Return3.23%4.67%Torrent
Price-to-Sales Ratio (TTM)8.1610.24Mankind Pharma
Enterprise Value$1,114.55B$1,236.95BTorrent
EV/Revenue Ratio8.6310.45Mankind Pharma
Gross Profit Margin (TTM)70.49%75.26%Torrent
Revenue per Share (TTM)$317$350Torrent
Earnings per Share (Diluted)$46.42$59.06Torrent
Beta (Stock Volatility)0.350.13Torrent
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Mankind Pharma vs Torrent Stock Performance Analysis

Loading Price Chart...

Mankind Pharma
Torrent
Mankind Pharma Stock Overview | Torrent Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Mankind Pharma0.38%2.32%4.55%9.45%14.17%-10.47%
Torrent0.84%0.80%1.11%13.59%17.64%5.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Mankind Pharma3.23%84.98%84.98%84.98%84.98%84.98%
Torrent4.67%144.33%25.61%154.99%1,164.71%4,769.79%

News Based Sentiment: Mankind Pharma vs Torrent

Mankind Pharma

News based Sentiment: MIXED

The month presented a mixed picture for Mankind Pharma, with positive analyst ratings and active investor engagement offset by a slight share price decline and a high valuation premium. While the company is making strategic moves to incentivize employees and improve transparency, investors should carefully consider the valuation and potential risks.

View Mankind Pharma News Sentiment Analysis

Torrent

News based Sentiment: POSITIVE

Torrent Pharmaceuticals reported strong Q1 FY26 results with double-digit revenue growth across key markets, leading to a 'BUY' rating reaffirmation from Mirae Asset Sharekhan and increased market interest. This positive momentum, coupled with strong operational efficiency, suggests a favorable outlook for investors, though limited insider trading data adds a note of caution.

View Torrent News Sentiment Analysis

Performance & Financial Health Analysis: Mankind Pharma vs Torrent

MetricMANKINDTORNTPHARM
Market Information
Market Cap i₹1.05T₹1.23T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i369,792178,478
90 Day Avg. Volume i511,787333,090
Last Close₹2,589.30₹3,643.30
52 Week Range₹2,132.00 - ₹3,054.80₹2,886.45 - ₹3,787.90
% from 52W High-15.24%-3.82%
All-Time High₹3,054.80 (Dec 23, 2024)₹3,787.90 (Jul 30, 2025)
% from All-Time High-15.24%-3.82%
Growth Metrics
Quarterly Revenue Growth0.23%0.11%
Quarterly Earnings Growth-0.18%0.20%
Financial Health
Profit Margin (TTM) i0.15%0.17%
Operating Margin (TTM) i0.18%0.26%
Return on Equity (TTM) i0.14%0.25%
Debt to Equity (MRQ) i58.4342.81
Cash & Liquidity
Book Value per Share (MRQ)₹347.39₹224.28
Cash per Share (MRQ)₹61.20₹20.33
Operating Cash Flow (TTM) i₹26.50B₹27.02B
Levered Free Cash Flow (TTM) i₹19.91B₹19.11B
Dividends
Last 12-Month Dividend Yield i0.04%17.47%
Last 12-Month Dividend i₹1.00₹552.76

Valuation & Enterprise Metrics Analysis: Mankind Pharma vs Torrent

MetricMANKINDTORNTPHARM
Price Ratios
P/E Ratio (TTM) i54.9560.60
Forward P/E i41.3440.41
PEG Ratio i-2.663.05
Price to Sales (TTM) i8.1610.24
Price to Book (MRQ) i7.3415.96
Market Capitalization
Market Capitalization i₹1.05T₹1.23T
Enterprise Value i₹1.11T₹1.24T
Enterprise Value Metrics
Enterprise to Revenue i8.6310.45
Enterprise to EBITDA i35.9132.56
Risk & Other Metrics
Beta i0.350.13
Book Value per Share (MRQ) i₹347.39₹224.28

Financial Statements Comparison: Mankind Pharma vs Torrent

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MANKINDTORNTPHARM
Revenue/Sales i₹35.70B₹31.28B
Cost of Goods Sold i₹10.54B₹7.74B
Gross Profit i₹25.17B₹23.54B
Research & Development iN/AN/A
Operating Income (EBIT) i₹6.28B₹8.31B
EBITDA i₹9.30B₹9.95B
Pre-Tax Income i₹5.40B₹7.38B
Income Tax i₹958.70M₹1.90B
Net Income (Profit) i₹4.45B₹5.48B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MANKINDTORNTPHARM
Cash & Equivalents i₹4.07B₹5.73B
Total Current Assets i₹69.88B₹56.23B
Total Current Liabilities i₹56.64B₹47.17B
Long-Term Debt i₹55.40B₹13.38B
Total Shareholders Equity i₹145.68B₹75.91B
Retained Earnings i₹119.07BN/A
Property, Plant & Equipment i₹29.08B₹2.99B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MANKINDTORNTPHARM
Operating Cash Flow i₹3.41BN/A
Capital Expenditures i₹-1.30BN/A
Free Cash Flow i₹3.51BN/A
Debt Repayment i₹-191.39MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricMANKINDTORNTPHARM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i369,792178,478
Average Daily Volume (90 Day) i511,787333,090
Shares Outstanding i412.58M338.45M
Float Shares i106.01M103.96M
% Held by Insiders i0.74%0.71%
% Held by Institutions i0.18%0.15%

Dividend Analysis & Yield Comparison: Mankind Pharma vs Torrent

MetricMANKINDTORNTPHARM
Last 12-Month Dividend i₹1.00₹552.76
Last 12-Month Dividend Yield i0.04%17.47%
3-Year Avg Annual Dividend i₹0.33₹198.92
3-Year Avg Dividend Yield i0.04%3.27%
3-Year Total Dividends i₹1.00₹596.76
Ex-Dividend DateAug 08, 2025Jun 20, 2025